What We're Reading: Page 305
Industry reads hand-picked by our editors
Mar 24, 2017
-
Crain's Chicago Business
Pharma gets roped into the Trumpcare maelstrom
-
The Wall Street Journal
Valeant CEO Joseph Papa was paid $62.7 million in 2016
-
San Francisco Business Times
Google life sciences spinoff soaks up huge space
-
TheStreet
CFO says Depomed to buy or be sold
-
Philly.com
How a theft in Northeast Philly led to a drug firm's conviction for a $180 million fraud
Mar 23, 2017
Mar 22, 2017
-
Business Insider
Something weird's going on with the doctors prescribing one of pharma's most controversial blockbuster drugs
-
Kaiser Health News
Trump’s promise to rein in drug prices could open floodgate to importation laws
-
The Advocate
Purdue Pharma seeks dismissal of Washington state city’s lawsuit
-
Boston Business Journal
As Cerulean Pharma winds down, executives get a parting gift: bonuses
-
The New York Times
‘Cure’ me? No, thanks
Mar 21, 2017
-
Bloomberg BNA
Sanofi, CVS, others accused of insulin price fixing
-
Science Daily
Gene editing technique helps find cancer's weak spots
-
NPR
Ketamine for severe depression: 'How do you not offer this drug to people?'
-
Voice of America
Experimental vaccine protects against two strains of malaria
-
In the Pipeline
What PCSK9 is telling us about drug discovery
Mar 20, 2017
-
Wired
Bacteria are brewing up the next generation of antivenoms
-
Time
The story behind the first AIDS drug
-
The Boston Globe
Biopharma facing stiffer opposition
-
MIT Technology Review
How a boy’s Lazarus-like revival points to a new generation of drugs
Mar 17, 2017
-
NPR
One way to force down drug prices: Have the U.S. exercise its patent rights
-
Bloomberg
Stada said to plan hike to profit guidance to increase bids
-
The Tennessean
Meningitis outbreak trial heads to jury
-
CNBC
The Martin Shkreli musical is bound for Off-Broadway, just as the 'pharma bro' heads to trial
Mar 16, 2017
-
Bloomberg
Coffee shop meeting inspires novel way to kill cancer
-
Big Molecule Watch
Summary of Amgen's opening and responsive brief in Sandoz v. Amgen
-
Boston Business Journal
Seres gets FDA mulligan on microbiome drug, eye pivotal trial
-
MIT Technology Review
CRISPR may speed pig-to-human transplants
Previous
